Bristol Myers Squibb Co. (BMY)
61.99
+2.47
(+4.15%)
USD |
NYSE |
Feb 06, 16:00
61.90
-0.09
(-0.15%)
Pre-Market: 20:00
Bristol Myers Squibb EPS Diluted (Quarterly) : 0.5326 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.098 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Janux Therapeutics, Inc. | -0.392 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.085B |
| Revenue (Quarterly) | 12.50B |
| Total Expenses (Quarterly) | 11.42B |
| Enterprise Value | 160.78B |
| Gross Profit Margin (Quarterly) | 71.84% |
| Profit Margin (Quarterly) | 8.68% |
| Earnings Yield | 5.58% |
| Operating Earnings Yield | 11.86% |
| Normalized Earnings Yield | 9.389 |